WEXFORD CAPITAL LP bought NEPH
August 18, 2026 · Form 4 insider transaction
WEXFORD CAPITAL LP bought 812 shares of Nephros, Inc. at $3.60 per share, a transaction worth $2.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
812
Price
$3.60
Total value
$2.9K
InsiderWEXFORD CAPITAL LP
RoleDirector, 10% owner
CompanyNephros, Inc. (NEPH)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after56,872
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the net number of shares of common stock issued upon the cashless exercise of stock options to purchase 3,765 shares, after a portion of the option shares was withheld to satisfy the exercise price.; Includes shares of common stock granted to Wexford Capital LP ("Wexford Capital") as reported in Form 4s previously filed by Arthur Amron, a current director of the Issuer and a former employee of Wexford Capital.